To explore the clinical significance of PER3 in PCa, we used IHC to examine PER3 expression level in a tissue microarray (TMA) consisting of hormone naïve 32 PCa patients and 16 benign/normal prostate tissue cores. The gene discussed is PER3; the disease is posterior cortical atrophy.